LVTX a possible continuation medical technology penny stock LONG

AwesomeAvani Updated   
BATS:LVTX   LAVA Therapeutics N.V.
LVTX is a pharmaceutical company focused on biologicals for advanced prostate carcinoma.

It recently secured a collaboration agreement with Merck to assist in the clinical trials and

the financial burdens it imposes in a quid pro quo related to a share of product margins in the

future. On the 15-minute chart, LVTX burst out of a long-standing consolidation cycle. The

majority of shareholders per Yahoo Finance are insiders and institutions primarily hedge funds.

These people are not clueless. This is a huge money inflow into the market cap. I intend

to follow the money as I see that price has retraced to a good Fibonacci level and with the

last candle may be on a reversal. I know that institutions tend to buy at the VWAP heavily

and as price is below VWAP the impetus is to buy discounted from VWAP. I will follow

the wisdom, experience and expertise of institutional traders. I will go long and assume the

risk of more of a drop with an ATR stop loss. My goal in the trade is to get a 20% gain by the

close on Monday. Getting into an insider trading move is tricky but it is interesting and

can be profitable.
Trade closed: stop reached:
Stopped out with a 5% loss. Will add to the watch list.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.